Growth Metrics

Intelligent Bio Solutions (INBS) Receivables - Other (2020 - 2025)

Intelligent Bio Solutions' quarterly Receivables - Other came in at $734408.0 in Q2 2025, up 11555.42% year-on-year from N/an in Q2 2024, and up 41.15% quarter-over-quarter from $520312.0 in Q1 2025.

Intelligent Bio Solutions has reported Receivables - Other for 6 years, with the latest figure at $734408.0 in Q2 2025.

  • For the quarter ending Q2 2025, Receivables - Other rose 11555.42% year-over-year to $734408.0; the trailing twelve-month figure through Jun 2025 stood at $734408.0 (up 11555.42% YoY), and the FY2025 full-year result was $734408.0, up 11555.42% from the prior year.
  • Receivables - Other for Q2 2025 stood at $734408.0, up from $520312.0 in the prior quarter.
  • The five-year high for Receivables - Other was $2.1 million in Q2 2021, with the low at $6301.0 in Q2 2024.
  • Average Receivables - Other over 5 years is $459216.7, with a median of $364367.5 recorded in 2022.
  • Year-over-year, Receivables - Other surged 17269.12% in 2021 and sank 99.28% in 2022.
  • Tracing INBS's Receivables - Other over 5 years: stood at $28157.0 in 2021, then soared by 124.39% to $63182.0 in 2022, then jumped by 357.67% to $289167.0 in 2023, then rose by 29.92% to $375687.0 in 2024, then jumped by 95.48% to $734408.0 in 2025.
  • The last three Receivables - Other figures came in at $734408.0 (Q2 2025), $520312.0 (Q1 2025), and $375687.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 734,408.00
Jun 30, 2025 734,408.00
Mar 31, 2025 520,312.00
Mar 31, 2025 520,312.00
Dec 31, 2024 375,687.00
Dec 31, 2024 375,687.00
Sep 30, 2024 648,334.00
Sep 30, 2024 648,334.00
Jun 30, 2024 6,301.00
Jun 30, 2024 6,301.00
Mar 31, 2024 332,471.00
Mar 31, 2024 332,471.00
Dec 31, 2023 289,167.00
Dec 31, 2023 289,167.00
Sep 30, 2023 559,588.00
Sep 30, 2023 559,588.00
Jun 30, 2023 498,758.00
Jun 30, 2023 498,758.00
Mar 31, 2023 578,456.00
Mar 31, 2023 578,456.00
Dec 31, 2022 63,182.00
Dec 31, 2022 63,182.00
Sep 30, 2022 7,050.00
Sep 30, 2022 7,050.00
Jun 30, 2022 353,048.00
Jun 30, 2022 353,048.00
Mar 31, 2022 181,598.00
Mar 31, 2022 181,598.00
Dec 31, 2021 28,157.00
Dec 31, 2021 28,157.00
Sep 30, 2021 982,898.00
Sep 30, 2021 982,898.00
Jun 30, 2021 2.10 Mn
Jun 30, 2021 2.10 Mn
Mar 31, 2021 7,602.00
Mar 31, 2021 7,602.00
Jun 30, 2020 12,084.00
Jun 30, 2020 12,084.00